Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: A review of 447 cases using a tissue microarray technique

Applied Immunohistochemistry and Molecular Morphology

Volumn 13, Issue 4, 2005, Pages 323-332

  Wang, Jinfen ^a   Young, Lillian ^b   Win, William ^b   Taylor, Clive R ^b  

^a SHANXI TUMOR HOSPITAL   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Distribution; Immunohistochemistry; Malignant lymphoma; Tissue microarray technique; WHO classification; ZAP 70

Indexed keywords

ANTISERUM; CD15 ANTIGEN; CD20 ANTIBODY; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; CD99 ANTIGEN; CHLORDANE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LEUKOSIALIN; MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN BCL 6; PROTEIN KINASE ZAP 70; RNA; T6 ANTIGEN; TRANSCRIPTION FACTOR PAX5;

ANAPLASTIC CARCINOMA; ARTICLE; B CELL LYMPHOMA; CANCER CENTER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CELL LINEAGE; CHINA; CLINICAL EXAMINATION; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; FREQUENCY ANALYSIS; HISTIOCYTIC LYMPHOMA; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPAN; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPHOCYTOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MATERIALS; NATURAL KILLER CELL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA PROBE; T CELL LYMPHOMA; T LYMPHOBLAST; TISSUE MICROARRAY; TISSUE SECTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHILD; CHINA; DEMOGRAPHY; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MIDDLE AGED; RNA, VIRAL; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 28144453094     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000176161.38402.b2     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. Cancer J Clin. 1999;49:33-64.
2. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9:717-720.
3. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute-sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982;49:2112-2135.
4. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
5. Chang KC, Huang GC, Jones D, et al. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leuk Lymphoma. 2004;45:1375-1384.
6. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
7. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors. Pathology & Genetics. Tumors of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press, 2001:239-253.
8. Chang X, Zulang S, Qiuliang W, et al. Clinical and pathological reassessment of 493 case of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasm. Chinese J Pathol. 2005;34:22-27.
9. Naresh KN, Agarwal B, Diebold NB, et al. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists. Leukemia Lymphoma. 2004;45:1569-1577.
10. Admirand JH, Rassidakis GZ, Abruzzo LV, et al. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol. 2004;17:954-961.
11. Carreras J, Villamor N, Colomo L, et al. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasm. J Pathol. 2005;205:507-513.
12. Wang JF, Taylor CR. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique. Applied Immunohistochem Mol Morph. 2003;11:206-213.
13. Shi Sh-R, Guo J, Taylor CR, et al. Antigen Retrieval Techniques: Immunohistochemistry and Molecular Morphology. Natick, MA: Eaton Publishing, 2002:311-353.
14. ILSG. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
15. Harris NL, Jaffe ES, Diebold J, et al. Lymphoma classification, from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol. 2000;11(Suppl 1): 3-10.
16. Kim H, Zelman RJ, Fox MA, et al. Pathology panel for lymphoma clinical studies: a comprehensive analysis of cases accumulated since its inception. J Natl Cancer Inst. 1982;68:43-67.
17. Whitcomb CC, Crissman JD, Flint A, et al. Reproducibility of morphologic classification of non-Hodgkin's lymphomas using the Lukes-Collins system. The Southeastern Cancer Study Group experience. Am J Clin Pathol. 1983;82:383-389.
18. NCI Non-Hodgkin's Classification Project Writing Committee. Classification of non-Hodgkin's lymphoma. Reproducibility of major classification systems. Cancer. 1985;55:91-95.
19. Dick F, Van Lier S, Banks P, et al. Use of the Working Formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnosis and a panel of experienced pathologists. J Natl Cancer Inst. 1987;78:1137-1144.
20. Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer. 1998;83:1197-1204.
21. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50:696-702.
22. Savagel KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004;15:1467-1475.
23. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single-center experience of 10 years. Ann Oncol. 2005;16:206-214.
24. Temmim L, Baker H, Al-Jarallah M, et al. Clinical characteristics and pathological classification of non-Hodgkin's lymphoma in Kuwait. Results of a collaborative study with the International Lymphoma Study Group (ILSG). Leukemia Lymphoma. 2004;45:1865-1871.
25. Attygalle A, Diss TC, Munson P, et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2004;28:54-61.
26. Attygalle A, Ai-Jehani R, Diss T, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99:627-633.
27. Levai LD, Savilo E, Longtine J, et al. Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol. 2001;25:395-400.
28. Schweighoffer E, Vanes L, Mathiot A, et al. Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion. Immunity. 2003;18:523-533.
29. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348:1764-1775.
30. Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101:4944-4951.